We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COV
476
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $1.46M | ﹤0.01% |
21,505
-13,218
| -38% | -$860K |
|
477
VeriSign
VRSN
$25.3B
| $1.45M | ﹤0.01% |
24,301
-700
| -3% | -$38.5K |
|
478
Vanguard Health Care ETF
VHT
$18.2B
| $1.45M | ﹤0.01% |
14,327
| – | – |
|
|
XWES
479
DELISTED
WORLD ENERGY SOLUTIONS INC NEW COMMON (DE)
XWES
| $1.44M | ﹤0.01% |
337,819
-55,000
| -14% | -$204K |
|
480
Equifax
EFX
$20.3B
| $1.42M | ﹤0.01% |
20,493
| – | – |
|
|
RP
481
DELISTED
RealPage, Inc.
RP
| $1.39M | ﹤0.01% |
59,637
+33,117
| +125% | +$787K |
|
|
GMCR
482
DELISTED
KEURIG GREEN MTN INC
GMCR
| $1.39M | ﹤0.01% |
18,334
| – | – |
|
483
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
| $1.36M | ﹤0.01% |
71,500
+16,500
| +30% | +$316K |
|
|
BDBD
484
DELISTED
BOULDER BRANDS INC
BDBD
| $1.35M | ﹤0.01% |
85,449
-1,610
| -2% | -$25K |
|
485
Carlyle Group
CG
$16.3B
| $1.34M | ﹤0.01% |
37,750
+2,000
| +6% | +$63K |
|
486
Vanguard Materials ETF
VAW
$3B
| $1.34M | ﹤0.01% |
+12,950
| New | +$1.29M |
|
487
Valmont Industries
VMI
$9.44B
| $1.31M | ﹤0.01% |
8,771
-89,813
| -91% | -$12.7M |
|
488
Lindsay Corp
LNN
$1.16B
| $1.3M | ﹤0.01% |
15,657
+300
| +2% | +$23.4K |
|
489
MiMedx Group
MDXG
$626M
| $1.29M | ﹤0.01% |
147,858
| – | – |
|
490
General Mills
GIS
$19.2B
| $1.29M | ﹤0.01% |
25,850
+10,805
| +72% | +$538K |
|
491
BP
BP
$113B
| $1.25M | ﹤0.01% |
31,467
+719
| +2% | +$26.8K |
|
492
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $1.24M | ﹤0.01% |
46,305
-7,520
| -14% | -$194K |
|
493
Archer Daniels Midland
ADM
$41.4B
| $1.23M | ﹤0.01% |
28,324
| – | – |
|
|
TRAK
494
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $1.22M | ﹤0.01% |
25,425
+10,100
| +66% | +$420K |
|
|
MWV
495
DELISTED
MEADWESTVACO CORP
MWV
| $1.22M | ﹤0.01% |
32,995
+250
| +0.8% | +$9.02K |
|
496
Illumina
ILMN
$29.4B
| $1.21M | ﹤0.01% |
+11,257
| New | +$1.03M |
|
|
XEC
497
DELISTED
CIMAREX ENERGY CO
XEC
| $1.21M | ﹤0.01% |
11,543
-228,220
| -95% | -$23.1M |
|
498
Carter's
CRI
$1.43B
| $1.21M | ﹤0.01% |
16,850
+11,050
| +191% | +$787K |
|
499
Devon Energy
DVN
$51.9B
| $1.21M | ﹤0.01% |
19,487
+3,640
| +23% | +$223K |
|
|
ITC
500
DELISTED
ITC HOLDINGS CORP
ITC
| $1.2M | ﹤0.01% |
37,455
-630
| -2% | -$20.1K |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.